Rickets

The Lancet

Volumn 383, Issue 9929, 2014, Pages 1665-1676

  Elder, Charlotte Jane ^a   Bishop, Nicholas J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; FIBROBLAST GROWTH FACTOR 23; PHOSPHATE; VITAMIN D; ALFACALCIDOL; CALCITRIOL; FIBROBLAST GROWTH FACTOR 23 ANTIBODY; UNCLASSIFIED DRUG;

BONE MINERALIZATION; CHEMOPROPHYLAXIS; CONFERENCE PAPER; DIET; DISEASE ASSOCIATION; GROWTH PLATE; HUMAN; HYPOCALCEMIA; HYPOPHOSPHATEMIA; HYPOPHOSPHATEMIC RICKETS; INCIDENCE; INFANCY; MEDICAL HISTORY; NONHUMAN; PATHOLOGIC FRACTURE; PATHOPHYSIOLOGY; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PREMATURITY; PREVALENCE; PRIORITY JOURNAL; RADIATION EXPOSURE; RICKETS; SUNLIGHT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; DIETARY INTAKE; FRACTURE; HYPERCALCEMIA; INFANT DISEASE; PHASE 1 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); SUN EXPOSURE; X LINKED HYPOPHOSPHATEMIC RICKETS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIET; HUMANS; HYPOPHOSPHATEMIA; INFANT; PHOSPHATES; RICKETS; SUNLIGHT; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84900329656     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)61650-5     Document Type: Conference Paper

References (110)

1. Wharton B, Bishop N. Rickets. Lancet 2003; 362: 1389-400.
2. Paterson D, Darby R. A study of rickets; incidence in London. Arch Dis Child 1926; 1: 36-38.
3. Craviari T, Pettifor JM, Thacher TD, Meisner C, Arnaud J, Fischer PR, for the Rickets Convergence Group. Rickets: an overview and future directions, with special reference to Bangladesh. J Health Popul Nutr 2008; 26: 112-21.
4. Ahmed SF, Franey C, McDevitt H, et al. Recent trends and clinical features of childhood vitamin D deficiency presenting to a children's hospital in Glasgow. Arch Dis Child 2011; 96: 694-96.
5. Loudon I. Deaths in childbed from the eighteenth century to 1935. Med Hist 1986; 30: 1-41.
6. Pettifor JM. Nutritional rickets. In: Glorieux FH, ed. Pediatric Bone; Biology and Diseases. San Diego: Academic Press; 2003: pp 541-65.
7. DeLucia MC, Mitnick ME, Carpenter TO. Nutritional rickets with normal circulating 25-hydroxyvitamin D: a call for reexamining the role of dietary calcium intake in North American infants. J Clin Endocrinol Metab 2003; 88: 3539-45.
8. Trousseau A. Lectures on Clinical Medicine, delivered at the Hotel-Dieu, Paris. London: New Sydenham Society, 1872.
9. Palm TA. The geographic distribution and etiology of rickets. Practitioner 1890; 15: 321.
10. Hess AF, Unger LJ. Prophylactic therapy for rickets in a Negro community. JAMA 1917; 19: 1583-86.
11. Mellanby E. An experimental investigation on rickets, 1919. Nutrition 1989; 5: 81-86.
12. Hess AF, Unger LJ. The cure of infantile rickets by sunlight - preliminary note. J Am Med Assoc 1921; 77: 39.
13. Daniels AL, Hutton MK, Stearns G, Hejinian LM. The relation of rate of growth in infants to diet. Am J Dis Child 1929; 37: 1177-86.
14. Jeans PC, Stearns G. effectiveness of vitamin D in infancy in relation to the vitamin source. Proc Soc Exp Biol Med 1934; 31: 1159-61.
15. Jeans PC, Stearns G. The effect of vitamin D on linear growth in infancy II. The effect of intakes above 1,800 USP units daily. J Pediatr 1938; 13: 730-40.
16. Hyppen E, Fararouei M, Sovio U, et al. High-dose vitamin D supplements are not associated with linear growth in a large Finnish cohort. J Nutr 2011; 141: 843-48.
17. Holick MF. Photosynthesis, metabolism and biologic actions of vitamin D. Rickets 1991; 21: 1-22.
18. Lanham-New SA, Buttriss JL, Miles LM, et al. Proceedings of the rank forum on vitamin D. Br J Nutr 2011; 105: 144-56.
19. Holick MF, Biancuzzo RM, Chen TC, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008; 93: 677-81.
20. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 2004; 101: 7711-15.
21. Kaseda R, Hosojima M, Sato H, Saito A. Role of megalin and cubilin in the metabolism of vitamin D(3). Ther Apher Dial 2011; 15 (suppl 1): 14-17.
22. Glorieux FH. Calcitriol treatment in vitamin D-dependent and vitamin D-resistant rickets. Metabolism 1990; 39 (suppl 1): 10-12.
23. Tiosano D, Gepstein V. Vitamin D action: lessons learned from hereditary 1,25-dihydroxyvitamin-D-resistant rickets patients. Curr Opin Endocrinol Diabetes Obes 2012; 19: 452-59.
24. Chen H, Hewison M, Hu B, Adams JS. Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: a cause of vitamin D resistance. Proc Natl Acad Sci USA 2003; 100: 6109-14.
25. Schlingmann KP, Kaufmann M, Weber S, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 2011; 365: 410-21.
26. Christakos S, Dhawan P, Ajibade D, Benn BS, Feng J, Joshi SS. Mechanisms involved in vitamin D mediated intestinal calcium absorption and in non-classical actions of vitamin D. J Steroid Biochem Mol Biol 2010; 121: 183-87.
27. Demay MB. Physiological insights from the vitamin D receptor knockout mouse. Calcif Tissue Int 2013; 92: 99-105.
28. Abrams SA, Hicks PD, Hawthorne KM. Higher serum 25-hydroxyvitamin D levels in school-age children are inconsistently associated with increased calcium absorption. J Clin Endocrinol Metab 2009; 94: 2421-27.
29. Need AG, O'Loughlin PD, Morris HA, Coates PS, Horowitz M, Nordin BE. Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res 2008; 23: 1859-63.
30. Sabbagh Y, Carpenter TO, Demay MB. Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. Proc Natl Acad Sci USA 2005; 102: 9637-42.
31. Masuyama H, Brownfield CM, St Arnaud R, MacDonald PN. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol Endocrinol 1997; 11: 1507-17.
32. Martin A, David V, Quarles LD. Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev 2012; 92: 131-55.
33. Harrell RM, Lyles KW, Harrelson JM, Friedman NE, Drezner MK. Healing of bone disease in X-linked hypophosphatemic rickets/ osteomalacia. Induction and maintenance with phosphorus and calcitriol. J Clin Invest 1985; 75: 1858-68.
34. Rowe PS. The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled. Cell Biochem Funct 2012; 30: 355-75.
35. Rowe PS. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway. Crit Rev Eukaryot Gene Expr 2012; 22: 61-86.
36. Staines KA, MacRae VE, Farquharson C. The importance of the SIBLING family of proteins on skeletal mineralisation and bone remodelling. J Endocrinol 2012; 214: 241-55.
37. Prideaux M, Loveridge N, Pitsillides AA, Farquharson C. Extracellular matrix mineralization promotes E11/gp38 glycoprotein expression and drives osteocytic Differentiation. PLoS One 2012; 7: e36786.
38. Whyte MP, Greenberg CR, Salman NJ, et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med 2012; 366: 904-13.
39. Bishop N. Bone disease in preterm infants. Arch Dis Child 1989; 64: 1403-09.
40. Bishop N, Sprigg A, Dalton A. Unexplained fractures in infancy: looking for fragile bones. Arch Dis Child 2007; 92: 251-56.
41. Lucas-Herald A, Butler S, Mactier H, McDevitt H, Young D, Ahmed SF. Prevalence and characteristics of rib fractures in ex-preterm infants. Pediatrics 2012; 130: 1116-19.
42. Chapman T, Sugar N, Done S, Marasigan J, Wambold N, Feldman K. Fractures in infants and toddlers with rickets. Pediatr Radiol 2010; 40: 1184-89.
43. Arundel P, Ahmed SF, Allgrove J, et al, and the British Paediatric and Adolescent Bone Group. British Paediatric and Adolescent Bone Group's position statement on vitamin D deficiency. BMJ 2012; 345: e8182.
44. Scientific Advisory Committee on Nutrition. Update on Vitamin D. Position statement by the Scientific Advisory Committee on Nutrition 2007. http://www.sacn.gov.uk/pdfs/sacn-position- vitamin-d-2007-05-07.pdf (accessed May 10, 2013).
45. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: 18-28.
46. Valcour A, Blocki F, Hawkins DM, Rao SD. effects of age and serum 25-OH-vitamin D on serum parathyroid hormone levels. J Clin Endocrinol Metab 2012; 97: 3989-95.
47. Shaw NJ, Mughal MZ. Vitamin D and child health: part 2 (extraskeletal and other aspects). Arch Dis Child 2013; 98: 368-72.
48. Callaghan AL, Moy RJ, Booth IW, Debelle GD, Shaw NJ. Incidence of symptomatic vitamin D deficiency. Arch Dis Child 2006; 91: 606-07.
49. Pearce SHS, Cheetham TD. Diagnosis and management of vitamin D deficiency. BMJ 2010; 340: b5664.
50. Davies JH, Shaw NJ. Preventable but no strategy: vitamin D deficiency in the UK. Arch Dis Child 2011; 96: 614-15.
51. Cancer Research UK, Diabetes UK, the Multiple Sclerosis Society, the National Heart Forum, the National Osteoporosis Society and, the Primary Care Dermatology Society. Consensus vitamin D position statement, 2010. http://www.cancerresearchuk.org/prod- consump/groups/cr-common/@nre/@sun/ documents/ generalcontent/cr-052628.pdf (accessed May 10, 2013).
52. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al, and the Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-30.
53. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Institute of Medicine 2010. http://books.nap.edu/ openbook.php?record-id= 13050 (accessed Nov 21, 2013).
54. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M, and the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008; 122: 398-417.
55. Aloia JF. Clinical Review: the 2011 report on dietary reference intake for vitamin D: where do we go from here? J Clin Endocrinol Metab 2011; 96: 2987-96.
56. Darling AL, Hart KH, Macdonald HM, et al. Vitamin D deficiency in UK South Asian Women of childbearing age: a comparative longitudinal investigation with UK Caucasian women. Osteoporos Int 2013; 24: 477-88.
57. Salle BL, Delvin EE, Lapillonne A, Bishop NJ, Glorieux FH. Perinatal metabolism of vitamin D. Am J Clin Nutr 2000; 71 (suppl): S1317-S24.
58. Greer FR. 25-Hydroxyvitamin D: functional outcomes in infants and young children. Am J Clin Nutr 2008; 88: 529S-33S.
59. Reeve LE, Chesney RW, DeLuca HF. Vitamin D of human milk: identification of biologically active forms. Am J Clin Nutr 1982; 36: 122-26.
60. Amukele TK, Soko D, Katundu P, et al. Vitamin D levels in Malawian infants from birth to 24 months. Arch Dis Child 2013; 98: 180-83.
61. Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011; 26: 2341-57.
62. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006; 116: 2062-72.
63. Pettifor JM. Vitamin D &/or calcium deficiency rickets in infants & children: a global perspective. Indian J Med Res 2008; 127: 245-49.
64. Agarwal KS, Mughal MZ, Upadhyay P, Berry JL, Mawer EB, Puliyel JM. The impact of atmospheric pollution on vitamin D status of infants and toddlers in Delhi, India. Arch Dis Child 2002; 87: 111-13.
65. Lo CW, Paris PW, Holick MF. Indian and Pakistani immigrants have the same capacity as Caucasians to produce vitamin D in response to ultraviolet irradiation. Am J Clin Nutr 1986; 44: 683-85.
66. Maiya S, Sullivan I, Allgrove J, et al. Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure. Heart 2008; 94: 581-84.
67. Robinson PD, Hler W, Craig ME, et al. The re-emerging burden of rickets: a decade of experience from Sydney. Arch Dis Child 2006; 91: 564-68.
68. Fraser WD, Milan AM, Vitamin D assays: past and present debates, difficulties, and developments. Calcif Tissue Int 2013; 92: 118-27.
69. Stepman HCM, Vanderroost A, Van Uytfanghe K, Thienpont LM. Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem 2011; 57: 441-48.
70. Tai SSC, Bedner M, Phinney KW. Development of a candidate reference measurement procedure for the determination of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Chem 2010; 82: 1942-48.
71. Roth HJ, Schmidt-Gayk H, Weber H, Niederau C. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem 2008; 45: 153-59.
72. Phinney KW, Bedner M, Tai SSC, et al. Development and certification of a standard reference material for vitamin D metabolites in human serum. Anal Chem 2012; 84: 956-62.
73. Singh RJ, Taylor RL, Reddy GS, Grebe SKG. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 2006; 91: 3055-61.
74. Lensmeyer G, Poquette M, Wiebe D, Binkley N. The C-3 epimer of 25-hydroxyvitamin D(3) is present in adult serum. J Clin Endocrinol Metab 2012; 97: 163-68.
75. Moln F, Sigiro R, Sato Y, et al. 1a,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor. PLoS One 2011; 6: e18124.
76. Prentice A. Vitamin D deficiency: a global perspective. Nutr Rev 2008; 66 (suppl 2): S153-64.
77. Thacher TD, Fischer PR, Strand MA, Pettifor JM. Nutritional rickets around the world: causes and future directions. Ann Trop Paediatr 2006; 26: 1-16.
78. Prentice A. Nutritional rickets around the world. J Steroid Biochem Mol Biol 2013; 136: 201-06.
79. Ashraf S, Mughal MZ. The prevalence of rickets among non-Caucasian children. Arch Dis Child 2002; 87: 263-64.
80. Matsuo K, Mukai T, Suzuki S, Fujieda K. Prevalence and risk factors of vitamin D deficiency rickets in Hokkaido, Japan. Pediatr Int 2009; 51: 559-62.
81. Beck-Nielsen SS, Brock-Jacobsen B, Gram J, Brixen K, Jensen TK. Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol 2009; 160: 491-97.
82. Ozkan B, Doneray H, Karacan M, et al. Prevalence of vitamin D deficiency rickets in the eastern part of Turkey. Eur J Pediatr 2009; 168: 95-100.
83. Munns CF, Simm PJ, Rodda CP, et al, and the APSU Vitamin D Study Group. Incidence of vitamin D deficiency rickets among Australian children: an Australian Paediatric Surveillance Unit study. Med J Aust 2012; 196: 466-68.
84. Pettifor JM. Nutritional rickets: deficiency of vitamin D, calcium, or both? Am J Clin Nutr 2004; 80 (suppl): S1725S-S29.
85. Aggarwal V, Seth A, Aneja S, et al. Role of calcium deficiency in development of nutritional rickets in Indian children: a case control study. J Clin Endocrinol Metab 2012; 97: 3461-66.
86. Thacher TD, Pettifor JM, Fischer PR, Okolo SN, Prentice A. Case-control study of breast milk calcium in mothers of children with and without nutritional rickets. Acta Paediatr 2006; 95: 826-32.
87. Thacher TD, Fischer PR, Pettifor JM, et al. A comparison of calcium, vitamin D, or both for nutritional rickets in Nigerian children. N Engl J Med 1999; 341: 563-68.
88. Office for National Statistics. 2011 Census, Key Statistics for Local Authorities in England and Wales. http://wwwonsgovuk/ons/rel/ census/2011-census/key-statistics-for-local-authorities-in-englandand- wales/rpt-international-migrantshtml. 20 (accessed May 10, 2013)
89. Armas LAG, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004; 89: 5387-91.
90. Holick MF, Biancuzzo RM, Chen TC, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008; 93: 677-81.
91. Gallo S, Phan A, Vanstone CA, Rodd C, Weiler HA. The change in plasma 25-hydroxyvitamin D did not differ between breast-fed infants that received a daily supplement of ergocalciferol or cholecalciferol for 3 months. J Nutr 2013; 143: 148-53.
92. Gordon CM, Williams AL, Feldman HA, et al. Treatment of hypovitaminosis D in infants and toddlers. J Clin Endocrinol Metab 2008; 93: 2716-21.
93. Paediatric Formulary Committee. British National Formulary for Children 2013. In: British Medical Association tRPSoGB, the Royal College of Paediatrics and Child Health, and the Neonatal and Paediatric Pharmacists Group, ed. 65. edn. London: BMJ Group and Pharmaceutical Press; 2013.
94. Hoppe B, Gnehm HE, Wopmann M, Neuhaus T, Willi U, Leumann E. Vitamin D poisoning in infants: a preventable cause of hypercalciuria and nephrocalcinosis. Schweiz Med Wochenschr 1992; 122: 257-62.
95. Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res 2011; 26: 1381-88.
96. Aono Y, Yamazaki Y, Yasutake J, et al. Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia. J Bone Miner Res 2009; 24: 1879-88.
97. Wagner CL, Greer FR, and the American Academy of Pediatrics Section on Breastfeeding, and the American Academy of Pediatrics Committee on Nutrition. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008; 122: 1142-52.
98. Farrar MD, Kift R, Felton SJ, et al. Recommended summer sunlight exposure amounts fail to produce sufficient vitamin D status in UK adults of South Asian origin. Am J Clin Nutr 2011; 94: 1219-24.
99. Farrar MD, Webb AR, Kift R, et al. Efficacy of a dose range of simulated sunlight exposures in raising vitamin D status in South Asian adults: implications for targeted guidance on sun exposure. Am J Clin Nutr 2013; 97: 1210-16.
100. Chief Medical Officers for the United Kingdom. Vitamin D - advice on supplements for at risk groups - letter from UK Chief Medical Officers, 2012. https://www.gov.uk/government/uploads/system/ uploads/attachment-data/file/ 213703/dh-132508.pdf (accessed May 10, 2013).
101. Mazhar SB. Vitamin D supplementation for women during pregnancy: RHL commentary. Geneva: World Health Organization; 2012.
102. Godel J. Vitamin D supplentation: recommendations for Canadian mothers and infants. Paediatr Child Health (Oxford) 2007; 12: 583-89.
103. De-Regil Luz M, Palacios C, Ansary A, Kulier R, Pe-Rosas Juan P. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev 2012; 2: CD008873.
104. Hollis BW, Wagner CL. Assessment of dietary vitamin D requirements during pregnancy and lactation. Am J Clin Nutr 2004; 79: 717-26.
105. European Food Safety Authority. Scientific opinion on the tolerable upper intake level of vitamin D. EFSA Journal 2012; 10: 2813.
106. Dunnigan MG, Glekin BM, Henderson JB, McIntosh WB, Sumner D, Sutherland GR. Prevention of rickets in Asian children: assessment of the Glasgow campaign. BMJ (Clin Res Ed) 1985; 291: 239-42.
107. Moy RJ, McGee E, Debelle GD, Mather I, Shaw NJ. Successful public health action to reduce the incidence of symptomatic vitamin D deficiency. Arch Dis Child 2012; 97: 952-54.
108. Taylor SN, Wagner CL, Hollis BW, Vitamin D supplementation during lactation to support infant and mother. J Am Coll Nutr 2008; 27: 690-701.
109. Calvo MS, Whiting SJ, Barton CN. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr 2004; 80 (suppl): S1710S-S16.
110. Pietrek J, Preece MA, Windo J, et al. Prevention of vitamin-D deficiency in Asians. Lancet 1976; 1: 1145-48.